News and Announcements
OncoSil Medical Investor Presentation March 2016
- Published March 24, 2016 12:05PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd March 2016, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to release its latest Investor Presentation, delivered at Bell Potter Securities Limited’s Emerging Leaders Day in Sydney.
The Presentation provides an overview and update on the Company’s activities and operations.
OncoSil Medical is focused on regulatory approval and commercialisation of its OncoSil™ brachytherapy technology. It aims to position OncoSil™ as an innovative, new medical radiation treatment for pancreatic cancer and other solid tumours – which have major unmet medical needs.
To view the Presentation please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
